National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant vaccinia-B7.1 vaccine
A recombinant vaccinia virus encoding the T-cell co-stimulatory molecule B7-1. Co-administration of recombinant vaccinia-B7.1 and a tumor-associated antigen in a cancer vaccine may enhance tumor-associated antigen-specific T-cell responses. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Recombinant Vaccinia-B7.1
rV-B7 (Recomb Vaccinia/B7)
Abbreviations:rV-B7.1
rV-B7.1 vaccine



Previous:recombinant TNF-related apoptosis-inducing ligand, recombinant transforming growth factor-beta-2, recombinant tumor necrosis factor family protein, recombinant tyrosinase-related protein-2, recombinant vaccinia prostate-specific antigen vaccine
Next:recombinant vaccinia-CEA(6D)-TRICOM vaccine, recombinant vaccinia-MUC-1 vaccine, recombinant vaccinia-multiepitope melanoma peptides-B7.1-B7.2 vaccine, recombinant vaccinia-NY-ESO-1 vaccine, recombinant vaccinia-TRICOM vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov